They demonstrated that a iP300w, a potent p300/CBP inhibitor, reversed CIC::DUX4 associated histone H3 acetylation marks and consequently suppressed CIC::DUX4 transcriptional activity while limiting tumor growth (Bosnakovski et al., 2021) (Table 2). The gene discussed is DUX4; the disease is neoplasm.